相关实验视频
Updated: Jul 13, 2026

13:32
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
HNP-1:通过多方面的功能,从结构到应用
Jiaqi Zhang1, Zhaoke Liu1, Zhihao Zhou1
1Department of Biochemistry and Molecular Biology, Center for Experimental Teaching of Basic Medical Science, School of Basic Medical Science, Wuhan University, Wuhan 430072, China.
Microorganisms
|February 26, 2025
概括
人类中性粒细胞-1 (HNP-1) 为抗生素提供了一个有希望的替代品,用于对抗感染. 研究探索其机制和微生物的生产,以对抗耐药病原体进行有效的临床使用.
科学领域:
- 这是天生的免疫力.
- 抗微生物是一种抗微生物.
- 分子生物学分子生物学
- 药物发现 药物发现
背景情况:
- 抗微生物 (AMP) 对于天生的免疫力至关重要,由于其抵抗逃避特性,它们可以替代常规抗生素.
- 人类中性粒细胞-1 (HNP-1),中性粒细胞的关键AMP,显示出对细菌和病毒的广泛活性.
- 由于生产的挑战和对其杀菌作用的不完全理解,HNP-1的临床使用受到限制.
研究的目的:
- 审查HNP-1的结构,功能,基因表达,分布和免疫作用.
- 阐明HNP-1的抗菌机制和潜在的治疗应用.
- 讨论HNP-1的微生物生物合成作为可扩展的生产方法.
主要方法:
- 对HNP-1的特性,功能和产生的文献综述.
- 对基因表达和规范HNP-1生产的调控因素的分析.
- 检查最近关于HNP-1内源杀菌机制和微生物生物合成的研究.
主要成果:
- HNP-1表现出广泛的抗菌活性.
- 微生物系统为HNP-1生物合成提供了具有成本效益的途径.
- 最近的研究正在澄清HNP-1的内源性杀菌机制.
结论:
- 对HNP-1的机制和产生的彻底理解对于其临床应用至关重要.
- 在抗生素耐药性感染方面,HNP-1具有显著的潜力.
- 微生物生物合成为大规模HNP-1生产提供了一个可行的策略.
相关概念视频
Intrinsically Disordered Proteins
17.7K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
17.7K
Protein Complexes with Interchangeable Parts
2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Structure of Cadherins
3.3K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins” is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
3.3K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Structure-Activity Relationships and Drug Design
483
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
483

